medical devices

Law firm investigates securities fraud claims against ASP Isotopes, Integer Holdings, Molina Healthcare, and Soleno Therapeutics for alleged misstatements regarding technology, competitive position, medical costs, and drug safety.

Tenon Medical reports 92% Q4 revenue growth to $1.5M, achieves 69% gross margins, secures FDA clearance and $4.3M financing for spine fusion device expansion.

Embecta to acquire UK firm Owen Mumford for up to $200M, bolstering drug-delivery capabilities and chronic care market reach. Stock rises 4.63%.

$ABT down 22% after disappointing earnings, but strong medical devices and $21B Exact Sciences deal offer recovery potential for income seekers.

Embecta agrees to acquire Owen Mumford Holdings for up to £150M, diversifying beyond insulin delivery into broader drug-delivery technologies.

Global surgical stapling devices market valued at $5.47B in 2025, projected to reach $10.14B by 2035, growing 7.2% annually driven by minimally invasive procedures and obesity.

UFPT executives to participate in KeyBanc Capital Markets virtual healthcare forum on March 18, with scheduled investor meetings.

Global IV solutions market projected to surge from $13.35B in 2025 to $29.47B by 2035, driven by rising chronic disease prevalence and critical care demand.

Intuitive Surgical posted strong Q4 results with 19% revenue growth, but 2026 guidance signals meaningful deceleration. At 63x earnings, stock appears fairly valued for current shareholders but overvalued for new investors.

Sono-Tek lands $820K medical device coating order with expected FY2027 shipment, expanding customer footprint across multiple diagnostic equipment programs.

ResMed trades at a 25% valuation discount despite 11% revenue growth and expanding digital health operations in 140+ countries, though Medicare reimbursement risks persist.

Medtronic acquires Scientia Vascular for $550M to strengthen neurovascular offerings. Deal closes H1 FY2027, minimally dilutive in 2027, then accretive.

Global microelectronics market projected to reach $1.6B by 2035 from $664M in 2025, driven by wearables, smartphones, and automotive demand.

Global IV infusion pump market projected to grow from $6.72B in 2025 to $14.02B by 2035 at 7.6% CAGR, driven by aging populations and smart pump technology.

Becton Dickinson and Medtronic offer attractive dividend yields of 2.4% and 2.9%, trading below $1,000 with growth potential amid sector pessimism.

BMY and MDT offer attractive dividend yields and growth potential, with BMY at 4% yield and MDT boasting 48 years of consecutive increases.

Boston Scientific positioned to capitalize on global aging through AFib, chronic pain, and Parkinson's treatments; recent acquisitions boost stroke capabilities.

NeuroPace shares rose nearly 1% after Q4 earnings beat expectations with $26.6M revenue (24% YoY growth) and narrowed losses, though 2026 guidance disappointed investors.

Medtronic ($MDT) wins FDA approval for Hugo surgical robot, trading at 27x P/E versus competitor Intuitive Surgical ($ISRG) at 64x, offering potential upside with 2.9% dividend yield.

Medtronic gains FDA approval for Hugo robotic surgery system and spins off diabetes division, strengthening market position while reporting 8.7% revenue growth and maintaining 48-year dividend streak.